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Abstract
Background: Catch-up growth after food restriction (CUGFR) is characterized by a significant change in food intake 
which could theoretically lead to the change in glucagon-like peptide-1 (GLP-1) secretion that consequently results in 
altered functions of pancreatic islets.
Methods: Experimental rats were divided into two groups. Rats in CUGFR group were put on food-restriction for 4 
weeks, and then allowed full access to food for 0, 2, 4 weeks respectively while rats in the control group were offered ad 
libitum access to food. Plasma glucose, insulin and GLP-1 level during OGTT were measured in all the rats. Moreover, 
morphology of intestinal mucosa, number of L cells, beta cell mass, incretin effect and the expression of GLP-1 receptor 
(GLP-1R) gene in the islets were also determined.
Results: The size of pancreatic islets, insulin concentration, plasma GLP-1 concentration, incretin effect, villus height-to-
crypt depth ratio and L cells were all significantly decreased in CUGFR group at the end of a 4-week food-restriction 
period as compared with the controls. Insulin concentration and the villus height-to-crypt depth ratio were increased 
and finally exceeded the level of the control group over a 4-week catch-up period. Nevertheless, at the conclusion of 
the study, islet size, L cells number, plasma GLP-1 concentration and incretin effect increased but failed to reach the 
levels of the controls.
Conclusion: CUGFR decreases incretin effect and disturbs the entero-insular axis partially by decreasing GLP-1 
concentration, which might be responsible for the increased risk of metabolic disorder during CUGFR.
Background
The term 'catch-up growth' was first introduced by
Prader in 1963[1], and following studies have shown that
nutritional rehabilitation after malnutrition could moti-
vate catch-up growth, which was characterized by rapid
growth following a temporary period of growth retarda-
tion[2] and apparent insulin resistance[3]. A relationship
between low birth weight and impaired glucose tolerance
late in life has been epidemiologically identified[4] and
the association between insulin resistance and impaired
f u n c t i o n  o f  t h e  p a n c r e a t i c  b e t a  c e l l s  i n  a d u l t h o o d  h a s
been confirmed[5]. Because of these findings, the link
between catch-up growth and later metabolic disorder
has become a subject of active investigation[6].
The gastrointestinal tract is a site where the body
exchanges energy with the external environment. The
individuals who have undergone catch-up growth after
food restriction show a significant increase in appetite
and food intake during nutritional rehabilitation[7]. The
change in the gastrointestinal load will inevitably lead to
alteration in the function of gastrointestinal tract.
The concept that intestinal hormones or 'incretins' are
involved in the augmentation of insulin secretion in
response to oral compared with intravenous glucose is
embodied in the classical descriptions of the 'entero-insu-
lar' axis[8]. The two major hormones of the entero-insu-
lar axis are believed to be glucose-dependent
insulinotropic polypeptide (GIP) and glucagon-like pep-
tide-1 (GLP-1)[9], which exert a number of important
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biological effects, including inhibition of glucagons and
somatostatin, maintenance of beta cell mass, delay of gas-
tric emptying, and inhibition of feeding[10]. Currently,
the control of incretin secretion represents a major goal
for new therapeutic as well as nutritional strategies for
treating and/or reducing the risk of hyperglycaemic syn-
dromes, excessive body weight and thus improving over-
all well-being[11].
Both human and animal studies showed that individu-
als who have undergone catch-up growth are at a higher
risk of developing the metabolic syndrome and type 2
diabetes compared to those who did not experience
catch-up growth, although the exact underlying mecha-
nisms are not fully understood. Catch-up growth after
food restriction (CUGFR) is reportedly characterized by a
significant change in food intake. Whether this fluctua-
tion of food intake leads to the change in GLP-1 secretion
and consequently alteration in the pancreatic islet func-
tion remains unclear. Therefore, the aim of this study was
to examine the impact of CUGFR on the entero-insular
axis and the possible mechanism underlying metabolic
disorder.
Methods
General Study design
6-week-old male Sprague-Dawley rats (Center of Experi-
mental Animals, Tongji Medical College, Huazhong Uni-
versity of Science and Technology, China), weighing 180-
200 g and caged singly in wire bottomed cages in a tem-
perature-controlled room (22 ± 1°C) with a 12-h light/
dark cycle, were raised on a commercial pellet diet (Cen-
ter of Experimental Animals, Tongji Medical College,
Huazhong University of Science and Technology, China)
consisting, by energy, of 22% protein, 66% carbohydrates,
and 12% fat and had free access to tap water. Animals
were maintained in accordance with regulations of the
institute and guidelines for the care and use of laboratory
animals. The experiments were conducted after 1-week
adaptation to housing conditions. All protocols of animal
treatment were approved by the institutional animal eth-
ics committee.
Animal model of catch-up growth
7-week-old rats (n = 36) were randomly divided into two
groups (Figure 1): a normal chow group (NC group; n =
18) and a CUGFR group (n = 18). Rats in NC group were
raised on a pellet diet ad libitum for 8 weeks and rats in
CUGFR group were put on food restriction for 4 weeks at
60% of the diet intake of ad libitum-fed rats and then
w e r e  r e -f ed wit h fr ee  a c c ess  t o pe ll et diet.  Cha ng es  in
food intake were determined once a day and body weight
was measured every 7 days. Six rats in each group were
sacrificed by decapitation 0 (the end of 4-week food
restriction), 2 (catch-up growth for 2 weeks), and 4
(catch-up growth for 4 weeks) weeks after re-feeding.
Oral glucose tolerance test
Two days before decapitation, an oral glucose tolerance
test (OGTT) was performed by orally administering 0.5
g/ml glucose solution at 1 ml/100 g body weight (5 g/kg).
In brief, the tip of the tail of a 20 h-fasted conscious rat
was cut off and tail vein blood samples were taken, and
then dextrose at 2 g/kg body weight was given by gavage.
Additional tail blood samples were then drawn from the
conscious rats 15, 30 and 60 min after the gavage. Blood
was collected with EP tube containing EDTA (1 mg/ml)
and aprotinin (5 × 105 kIU/L; Sigma, Oakville, ON, Can-
ada) as previously reported by Reimer et al[12]. Diprotin
A, an inhibitor of dipeptidyl peptidase IV was added to
the blood sample at 34 μg/ml (Calbiochem, La Jolla, CA)
to inhibit GLP-1 degradation. Blood was centrifuged at
1,600 g for 15 min at 4°C and plasma was stored at -80°C
for later radioimmunoassay.
Determination of plasma glucose, insulin and GLP-1
Plasma glucose was measured by employing a One Touch
Basic blood glucose monitoring system (Lifescan Canada
Ltd., Burnaby, British Columbia, Canada). Radioimmuno-
assay kits for insulin and active GLP-1 (7-36 amide) were
obtained from Linco Research (St. Louis, MO, USA). For
insulin determination, the sensitivity of the kit was <
17.22 pmol/l and intra-assay coefficient of variation was <
9.4% at 631.74 pmol/l. For GLP-1 (7-36 amide) assays,
sensitivity was < 3 pmol/l and intra-assay coefficient of
variation was < 12% at 40 pmol/l. Area under the curve
(AUC), which reflects the area above baseline, was deter-
mined as reported by Massimino et al[13].
Measurement of incretin effect
Two experiements were carried out after an overnight
fast (20 hours) at an interval of 2 days. In the first experi-
ment, rats received a 1-h OGTT (5 g/kg body weight)
with plasma glucose, insulin and GLP-1 concentrations
measured 0, 15, 30 and 60 min after gavage. With the sec-
ond experiment, the plasma glucose profile was repro-
duced by a variable intravenous (IV) glucose (20%
dextrose) infusion and the infusion rate was adjusted to
match the glucose concentrations during the OGTT. In
this experiment, venous blood was sampled 0, 15, 30 and
60 min after the start of glucose infusion for plasma glu-
cose and insulin determination by using aforementioned
method. For each rat, the incretin effect was calculated
from the insulin responses during the OGTT and
matched intravenous glucose infusion using the following
formula[14]: 100×(Insulin AUCOGTT-Insulin AUCIV glu-
cose)/Insulin AUCOGTT. This calculation eliminated theChen et al. Nutrition & Metabolism 2010, 7:45
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impact of glucose levels per se, which were matched by
design.
Immunohistochemistry and morphometry
Pancreata were resected, cleared of fat and spleen,
weighed, fixed, and embedded in paraffin. 3-μm sections
were deparaffinized and stained. Mouse anti-rat insulin
polyclonal antibody (1:100; Boster Biotech Inc., Wuhan,
China) was used for the immunofluorescence staining
and tissues were processed as described[15]. Beta cell
mass was morphometrically determined as described
previously[16]. For negative controls, non-immune
serum instead of primary antibody was used. Since we
previously found that the effect of food-restriction on
pancreatic islet size was greater in the head than in the
tail of the pancreas (data not shown), for each animal,
four representative sections of pancreas from the head
region were selected for analysis.
Mucosal samples from ileum of rats were fixed in 10%
buffered formalin and paraffin-embedded. Sections for
histological evaluation were obtained from tissue blocks
cut perpendicular to the mucosal surface, and stained
with haematoxylin and eosin. Images were recorded on a
digital camera (Coolpix 950, Nikon, Japan) and an Image
Pro Plus software package (Media Cybernetics, Bethesda,
MD, USA) was used to measure the height of 10 villi and
the depth of 10 crypts in each section on randomly-
selected microscopic fields [17]. The glucagon antiserum
(1:100; Boster Biotech Inc., Wuhan, China) is a polyclonal
antiserum which can react against enteroendocrine L
cells[18]. For immunohistochemistry, tissues were pro-
cessed and L cell size was calculated by morphometric
analysis as previously described[19].
RT-PCR and quantitative real-time PCR
The bile ducts of anesthetized rats were cannulated with
a 27-gauge needle, and the pancreas was distended with a
solution containing 2 mg/ml collagenase. Each pancreas
was then incubated in a tissue culture flask at 37°C and
the islets isolated according to the method reported by
Gotoh et al [20]. Total RNA was extracted from the islets
by using Simply P total RNA extraction kit (BioFlux,
Hangzhou, China). Reverse transcription was performed
with 1 μg of total RNA as sample material and oligo(dT)20
as a primer by using the first strand cDNA synthesis kit
(Toyobo Co., Ltd., Osaka, Japan). The resultant cDNA
was amplified using primers (synthesized by Sangon Inc.
Shanghai, China), and PCR reaction was performed in a
thermal cycle. Expression of the glucagons-like peptide-1
r e c e p t o r  ( G L P - 1 R )  g e n e  w a s  f i r s t  d e t e c t e d  b y  R T -
PCR[21,22], and then real-time quantitative PCR was
performed using the following profile. Primer sequences
for rat GLP-1R were: 5'-GCTGGACCAGGAACTCCA-
ACA-3' (forward) and 5'-ATGCAGATGAC CCGGAT-
GAAG-3' (reverse). The primer sequences for beta actin
gene were 5'-CGTTGACATCC GTAAAGAC-3' (for-
ward) and 5'-TGGAAGGTGGACAGTGAG-3' (reverse).
The two-step real-time quantitative PCR was done by
using the SYBR Premix ExTaq (TaKaRa Biotechnology
Co. Ltd., Dalian, China) and was heated at 95°C for a min-
imum time of 30 s, then 40 cycles at 95°C for 15 s and
60°C for 45 s in a DNA iCycler apparatus (BIO-RAD,
Mississauga, ON, Canada). Results were presented as the
relative expression level, which were fold ratio to the NC0
group (set to 1).
Statistical analysis
Data analyses were performed by employing SPSS 13.0
statistical software package (SPSS, Chicago, IL, USA).
Data were expressed as means ± SD. Differences between
the groups were evaluated by using independent t-test,
and considered as statistically significant at p < 0.05.
Results
Food intake and body weight
Rats in CUGFR group were fed with only 60% of the diet
intake of ad libitum-fed rats (normal intake) during food
restriction. Our previous study showed that the body
Figure 1 The diagram of experiment design. Rats were divided into NC group (n = 18) and CUGFR group (n = 18). The arrows indicate the specific 
days on which rats were sacrificed.
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weight of the rats remained roughly the same during the
whole restriction period. However, decreased body
weight and malnutrition resulted if they were fed with
less than 60% of the normal intake (data not shown).
After re-feeding, the food intake in CUGFR group
increased rapidly in the first 2 weeks to reach virtually the
same level as that of the control group (Figure 2-A). The
body weight of these rats, however, was consistently
lower than that of the control group, even four weeks
after the re-feeding (Figure 2-B).
Beta cell mass and function
HE and insulin fluorescence staining (Figure 3, 4) exhib-
ited that the relative area and mass of beta cells were sig-
nificantly less in CUGFR group than in NC group during
food-restriction. After re-feeding, the relative area and
mass of beta cells increased gradually over time, but they
failed to return to level of the controls even 4 weeks after
the catch-up growth.
Plasma glucose and insulin levels at the conclusion of
food-restriction session were slightly lower than or simi-
Figure 2 Food intake and body weight during food restriction and re-feeding stage. All values are expressed as means ± SD (n = 6). *P ≤ 0.05 
versus NC group; **P ≤ 0.01 versus NC group. The arrows indicate the specific days on which oral glucose tolerance tests (OGTTs) were performed.
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lar to those of NC group 0, 15, 30 and 60 min after glu-
cose gavage (Figure 5-A1, B1). Two weeks after the catch-
up growth, plasma glucose remained lower in CUGFR
group than in the NC group (Figure 5-A2) whereas
plasma insulin was higher than that of controls 15 min
after the gavage (Figure 5-B2). Four weeks after the catch-
up, plasma glucose was still lower in CUGFR group than
in NC group. However, plasma insulin levels were higher
than those of controls at all time points of OGTT, espe-
cially 30 min after the gavage (Figure 5-A3, 5-B3).
Plasma GLP-1 concentration and GLP-1R mRNA expression 
in islets
Food-restriction resulted in a significant decrease in
plasma GLP-1 level. Following re-feeding, GLP-1
increased but did not arrive at the level of NC group even
4 weeks after the catch-up (Figure 5-C).
As expected, electrophoresis of RT-PCR products of
the pancreatic GLP-1 receptor yielded a single band (Fig-
ure 6-A1). A control PCR run with no pancreatic islet
RNA or no primers yielded no product. Identity of every
distinct band was confirmed by direct sequencing (data
not shown). Expression levels of the GLP-1 receptor gene
were compared between NC and CUGFR groups 0, 2 and
4 weeks after the catch-up growth. GLP-1R expression
ratio increased significantly in the CUGFR group during
food restriction. However, catch-up growth blunted this
trend, and GLP-1R expression ratio declined with time
and was even lower than that of NC group after 4-week
catch-up growth (Figure 6-A2).
Incretin effect
The glucose concentrations were well matched between
the OGTT and isoglycemic IV glucose test (IsoG IVGT)
in all groups (Figure 7 A1-A3). However, the insulin
response was greater after oral than intravenous glucose
before or after re-feeding, which has been generally
known as "incretin effect" (Figure 7 B1-B3). The incretin
effect was decreased significantly after food restriction
compared with NC group. After re-feeding, the incretin
effect remained consistently lower in the re-feeding
group till the end of the study (Figure 8).
Figure 3 HE Staining (×400 magnification) and insulin immuno-
fluorescence staining (×200 magnification) in a rat pancreatic is-
let. Islet cells in the NC (A1 and B1) and CUGFR (A2 and B2) groups 4 
weeks after catch-up growth with HE staining (A1 and A2) and insulin 
fluorescence staining (B1 and B2). Green fluorescence shows cells pos-
itive for insulin.
A1 A2
B1 B2
Figure 4 Effect of catch-up growth on beta cell relative area and mass. After insulin staining of rat pancreatic islet, the area positively stained for 
insulin was quantified by Image Pro Plus software. Values are means ± SD (n = 6). *P < 0.05 versus NC group. **P < 0.01 versus NC group.
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The morphology of intestinal mucosa and number of 
glucagon-positive cells in the ileum
The morphological measurements of the rat's ileum
mucosa are presented in Figure 9A and Table 1. Both vil-
lus height and villus height-to-crypt depth ratio
decreased during food restriction. However, catch-up
growth increased villus height and decreased the crypt
depth, thereby resulting in a villus height to crypt depth
r a t i o  h i g h e r  t h a n  t h a t  o f  NC  gr o u p .  N ev e rt h e l e s s,  t h i s
trend weakened over the time of catch-up growth.
Figure 9B and Figure 10 show that there were fewer glu-
cagon-positive cells in CUGFR group than in NC group
at the end of food restriction. Although catch-up growth
partially moderated this trend, the number of glucagon-
positive cells in CUGFR group failed to catch up with
those of NC group even 4 weeks after the catch-up
growth.
Discussion
The importance of gut-endocrine pancreas interaction on
glucose metabolism was first recognized by Claude Ber-
nard about a century ago[23] and further conceptualized
by Zunz and La Barre who introduced the term "incre-
tins", which describe a family of hypoglycemic factors
found in the extract of duodenum[24]. On the basis of
understanding of the influence of the gut on pancreatic
islet functions, in 1969, Unger and Eisentraut integrated
these notions under a single concept of "entero-insular
axis"[25]. The entero-insular axis represents a network of
neural and endocrine communications between the ali-
mentary tract and the pancreatic islets, which promotes
insulin release in response to feeding. Although approxi-
mately 30% of the oral glucose-induced insulin secretory
effect was accounted for by GIP, Bell and colleagues pre-
dicted the existence of GLP-1 based on their studies of
Figure 5 Effect of catch-up growth on islet function and GLP-1 concentration. Plasma glucose (A), insulin (B), GLP-1(C) levels and AUCInsulin, AUC-
Glucose, AUCGLP-1 during a 1-hour OGTT, which was conducted 0 (A1, B1 and C1), 2 (A2, B2 and C2) and 4 (A3, B3 and C3) weeks after catch-up growth 
in the NC (red) and CUGFR (green) groups, were measured. Data are expressed as means ± SD of six rats in each group. *P ≤ 0.05 versus NC group; **P 
≤ 0.01 versus NC group.
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the proglucagon gene[26] and subsequent investigations
confirmed that GLP-1 is the most important post-pran-
dial hormone responsible for insulin secretion[27,28].
Catch-up growth falls into two types in terms of age[2].
Early catch-up growth refers to children who are born
small but catch up in weight and height in infancy or early
childhood. Late catch-up growth affects children who
may or may not be born small, but become stunted in
infancy, childhood or adulthood and catch up later in
weight, becoming "stunted-obese". The latter is more
commonly seen, as it can happen in many cases, such as
rapid economic development in developing countries,
migration from rural to urban settings, war, famine, reha-
bilitation from chronic diseases, yo-yo phenomenon
(weight suppression by low caloric diet, and weight
rebound later), and so on[29,30]. It has been suggested
that late catch-up growth may be associated with the
development of type 2 diabetes and other metabolic dis-
eases. In order to simulate the effects of late catch-up
growth in human adults, the most prevalent form in
developing countries, our study was conducted in mature
rats and late catch-up growth was observed at different
time points (0, 2, 4 weeks after re-feeding), with an
attempt to examine the impact of catch-up growth on the
entero-insular axis over time.
In this study, food intake and body weight of the rats as
well as insulin secretion increased markedly 2 weeks after
re-feeding, suggesting that catch-up growth started.
Although the number of L cells and GLP-1 concentration
increased at that time, the incretin effect did not parallel
the increase in GLP-1, which might be ascribed to the
decrease in GLP-1R. Food intake, body weight, beta cell
mass and insulin concentration increased with the time
of catch-up growth. On the other hand, L cell number
and GLP-1 did not increase correspondingly, resulting in
no increase in the incretin effect. It seems that the catch-
up in the incretin effect lags far behind catch-up in food
intake and body weight, which might be an important
mechanism by which catch-up growth leads to metabolic
disorder.
The metabolic syndrome may occur in both types of
catch-up growth and most studies on the mechanisms of
catch-up growth had focused on insulin resistance[31].
Although some evidence [32,33] suggests that pancreatic
islet dysfunction can result from early catch-up growth,
so far whether late catch-up growth also affects the beta
cells has not been studied. In this study, although beta cell
functions remained fundamentally normal 4 weeks after
catch-up growth, in view of the lowered incretin effect
and the diminished islet size, the pancreatic islets would,
presumably, eventually be unable to maintain insulin
secretion if the blood glucose increased excessively and
rapidly over the time of catch-up growth. The question
will arise as to whether in the long run this beta cell dys-
function will lead to the development of diabetes. This
issue is beyond the scope of this study and will be investi-
gated in our later studies.
This study was designed to verify whether or not the
fluctuation of food intake during CUGFR leads to the
change in GLP-1 secretion and thereby affects the beta
cell function. Therefore, we examined the pancreatic islet
size, insulin concentration and plasma GLP-1 concentra-
tion during CUGFR. Our results showed that pancreatic
islet size was diminished, insulin concentration was low-
ered, and plasma GLP-1 concentration and incretin effect
were significantly decreased at the end of the 4-week food
restriction period. After 4-week catch-up growth,
although both insulin and GLP-1 concentration in
CUGFR group were increased, the plasma GLP-1 level
still did not match that of the control group. Recent epi-
demiological and clinical studies demonstrated that indi-
viduals experiencing catch-up growth are more at risk of
developing central obesity, glucose intolerance, type 2
diabetes mellitus and cardiovascular diseases, which are
all encompassed in the definition of metabolic syn-
drome[30]. We believe that the changes in GLP-1 concen-
tration and islet function play a vital role in the
development of above-mentioned conditions. In accor-
dance with our inference, Stoffers [34] was intrigued by
the potential for GLP-1 agonist administration during the
pre-diabetic period to ameliorate or prevent the later
onset of diabetes. They used a surgical model of intra-
uterine growth retardation(IUGR) in which bilateral uter-
Figure 6 Effect of catch-up growth on GLP-1R mRNA expression 
in islets. A1. RT-PCR products from RNA extracted from rat (n = 5-6 per 
group) pancreatic islets. The beta actin control was comparable in all 
groups. A2. The statistical results of real time quantitative PCR products 
from RNA extracted from rat pancreatic islets. Data are expressed as 
means ± SD. *P ≤ 0.05 versus NC group.
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ine artery ligation is carried out on the rat gestation day
19 and found that, at 3 months of age, all vehicle treated
IUGR rats developed overt diabetes in association with a
90% decrease in beta cell mass. However, exenatide -4-
tr ea t ed IUGR ra ts maintained a normal beta ce ll mass
and normal glucose tolerance. The normalization of
blood glucose was maintained beyond 8 months of age
and appeared to represent a lifelong prevention of diabe-
tes.
Since GLP-1R, a G-protein-coupled receptor, selec-
tively locates on the beta cells[35] to serve as a regulator
of pancreatic islet mass and function, we examined the
GLP-1R mRNA expression in the process of catch-up
growth. We observed an increase in GLP-1R expression
ratio during the food restriction period, which, together
with the decrease in glucose and GLP-1 concentration,
suggests that a negative feedback mechanism exists
between GLP-1 and GLP-1R. This notion is consistent
with the speculation put forward by Abraham et al[36]
who speculated that the expression of the GLP-1R cou-
pled with the expression of proglucagon and resultant
GLP-1 may establish an autocrine/paracrine hormonal
feedback loop that is important for some physiological
functions.
G L P - 1  i s  r e l e a s e d  f r o m  L  c e l l s  o f  t h e  i n t e s t i n e s [ 3 7 ] .
However, whether GLP-1 secretion is related to the
change in the number of L-cells during CUGFR is not
clear. Hence, in this study we further investigated the
intestinal morphology and the change in L cell number.
Figure 7 Time course of the glucose and insulin following oral and IV glucose in the normal and catch-up growth rats. Plasma glucose (A1, 
A2, A3) and insulin (B1, B2, B3) concentrations in rats of NC group (red) or CUGFR group (green) during oral glucose tolerance test (solid line) and in-
travenous glucose infusion test (broken lines) designed to match the oral glucose curve in six rats, were detected after catch up growth for 0 (A1, B1), 
2(A2, B2) and 4 (A3, B3) weeks. Data are expressed as means ± SD.
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Figure 8 Effect of catch-up growth on the incretin effect. Data are 
expressed as means ± SD. The incretin effect was calculated by com-
paring the insulin response to oral and matched IV glucose load. * P ≤ 
0.05 versus NC group.
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Some studies examined the relationship between food
restriction and gastrointestinal function and demon-
strated that the growth, function, and repair of gut
mucosa are highly dependent on nutrient availability, and
that nutritional status is associated with expression of
various endogenous intestinal growth factors[38]. In line
with these findings, our study showed that food restric-
tion reduced villus height and crypt depth, resulting in
fewer L cells and inevitably leading to lower plasma GLP-
1 concentration and decreased incretin effect. When re-
feeding starts, the increase in the gastrointestinal load
motivates gut mucosal growth. The most urgent task for
the body then is to create more intestinal villi so as to
absorb and transport more nutrients instead of creating
more L cells. Cani et al[19] hypothesize that L-cells, like
other intestinal cells, come from common stem cells.
Therefore, we can postulate that, since stem cells are
available in limited amounts, the formation of L cells will
be inadequate, resulting in insufficient GLP-1 concentra-
tion and weaker incretin effect even after re-feeding.
However, the exact mechanisms warrant further study.
Conclusion
Although no diabetes was observed during our study,
there existed obvious secretory defects of GLP-1 and
weaker incretin effect in our murine model during a 4-
week catch-up growth period after food restriction, dem-
onstrating that catch-up growth could impair entero-
insular axis due to disturbed L cell formation. The
detailed mechanisms remain unclear and the subsequent
development of diabetes cannot be predicted at present.
Therefore, further studies are needed to establish the link
between the catch-up growth-related change in the
entero-insular axis and diabetes mellitus.
Figure 9 HE Staining (×200 magnification) and glucagon staining 
(×400 magnification) in rat ileum. Ileal villus observed in the CUGFR0 
(A1) and CUGFR2 (A2) groups with HE staining and NC4 (B1) and 
CUGFR4 (B2) groups with glucagon staining. Arrow shows a glucagon-
positive cell.
A1 A2
B1 B2
Table 1: Effects of catch-up growth on the morphology of the intestinal mucosa in rat ileum.
Items Villus height (μm) Crypt depth (μm) Villus height:crypt depth
NC0 260 ± 26 116 ± 13 2.24 ± 0.12
NC2 268 ± 20 123 ± 21 2.18 ± 0.53
NC4 264 ± 24 128 ± 21 2.06 ± 0.41
CU0 204 ± 26b 111 ± 16 1.84 ± 0.63b
CU2 302 ± 15a 95 ± 22b 3.18 ± 0.92b
CU4 284 ± 25 102 ± 19a 2.78 ± 0.45a
Data are expressed as means ± SD. a P ≤ 0.05 versus NC group; b P ≤ 0.01 versus NC group.
Figure 10 Effect of catch-up growth on glucagon-positive cells 
per high-power field. To quantify the expression of glucagon, an av-
erage of 50 sections of rat ileum from each of two animals were exam-
ined. The number of cells immunoreactive for glucagon was 
determined. Data are expressed as means ± SD. *P ≤ 0.05 versus NC 
group; **P ≤ 0.01 versus NC group.
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